Morgan Group Holding Co. (MGHL)
OTC PINK OTC PINK Primary 
Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025
NEWARK, CA / ACCESSWIRE / December 19, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D.
What's Happening With Morgan Stanley Stock?
Morgan Stanley's stock (NYSE: MS) gained about 42% year-to-date. This compares to rival Goldman Sachs stock, which has seen its stock gain about 55% year-to-date.
Morgan Stanley Collaborates With Wise to Enhance Payment Capabilities
MS joins forces with Wise to enhance its foreign exchange settlement capabilities, boost its existing product suite and offer fast-paced services to corporate clients.
Morgan Stanley or Goldman: Which Stock to Keep an Eye on in 2025?
MS and GS are well-poised to gain from the revival of global M&As. Read on to know whether to bet on these stocks now or wait.
Nvidia's stock is very attractive at this level, says Morgan Stanley's Joseph Moore
Joseph Moore, Morgan Stanley semiconductor analyst, joins 'Squawk Box' to discuss Nvidia's recent stock slide, what the fair value of the company is, and more.
3 Stocks J.P. Morgan Just Upgraded and Why They're Bullish
Whenever analysts from Wall Street's biggest banks decide to come together to boost a particular group of stocks, retail investors do well to watch the trends, attempt to reverse engineer their views and opinions, and, more importantly, where they stem from. Confident analysts often land on a bullish or bearish view of a particular industry, where select stocks will gain more market attention.
Morgan Stanley Taps Wise Platform to Accelerate Cross-Border Settlements
Morgan Stanley will offer its clients high-speed cross-border settlements through Wise Platform. The investment bank tapped this solution from Wise, a global technology focused on money movement, to facilitate foreign exchange international settlement for its corporate and institutional clients, the companies said in a Tuesday (Dec. 17) press release.
Morgan Stanley Direct Lending: High Quality At 9.4% Yield, Does Not Get Better Than This
My first bullish piece on MSDL was issued back in April 2024. It was also the second article covering MSDL on Seeking Alpha. Since the publication of my thesis, MSDL has gradually become a 'household name' among BDC investors. The good news is that looking at the current financials, the case for durable, close to double digit yield, remains intact.
Morgan Stanley Direct Lending Is Too Good To Miss Out On; Highly Defensive
Morgan Stanley Direct Lending Fund is a highly defensive BDC focusing on first-lien debt in non-cyclical sectors, ensuring stable cash flows and low technological risks. The current regular DPS coverage is attractive at ~119%, but further Fed rate cuts could impact dividend coverage due to MSDL's floating-rate debt investments. MSDL's valuation is appealing, with the potential to reestablish the premium, ensuring capital gathering effectiveness.
Kinder Morgan, Sunoco Offer 2025 Guidance for Midstream Investors
Kinder Morgan (KMI) and Sunoco LP (SUN) are among the latest midstream companies to provide financial guidance for 2025. Outlooks for EBITDA and dividend growth provide helpful visibility for investors.
Lowe's Positioned For Growth Amid Cost Savings And Housing Recovery: JP Morgan Analyst
JP Morgan analyst Christopher Horvers maintained an Overweight rating for Lowe's Companies, Inc. LOW with a price forecast of $300.
Kinder Morgan Trades at Cheap Valuation: Is the Stock a Buy Now?
Escalating natural gas demand and stable take-or-pay contracts brighten KMI's prospects. However, there are some uncertainties engulfing the firm.
